KingstronBio
KingstronBio manufactures artificial heart valves and annuloplasty rings
About KingstronBio
Kingstron Bio is a pioneering company in the biotechnology sector, focusing on the development of new medical treatments through technological innovation. The company collaborates with scientists worldwide to advance medicines from laboratory research to clinical applications, aiming to bring Chinese innovations to the global market. Kingstron Bio serves healthcare professionals and patients by providing more efficient and cost-effective treatment options. Operating primarily in the pharmaceutical and medical technology markets, the company generates revenue through strategic funding and the commercialization of its innovative medical solutions. Notably, Kingstron Bio has secured over 300 million yuan in strategic funding for its projects, including groundbreaking work in heart treatment technologies and combating calcification. The business model revolves around multidisciplinary collaboration to achieve medical breakthroughs and improve patient outcomes.
Source: Dealroom company dataAt a glance
- Founded
- 2012
- Headquarters
- China
- Sector
- Health
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Tengye Venture Capital
Series A4 investors entered at this stage
Cowin Capital
Yuansheng BioVenture- PVProsperico Ventures
Shenzhen Salubris Pharmaceuticals
Series B and later5 investors entered at this stage
Sequoia
Pan-Lin Asset Management
GF Qianhe- EMEverbright Financial Holding Asset Management
HaoYue Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about KingstronBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See KingstronBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.